Graphite Bio Inc

Company Profile

Graphite Bio Inc had its IPO on 2021-06-25 under the ticker symbol GRPH.

The company operates in the Healthcare sector and Biotechnology industry. Graphite Bio Inc has a staff strength of 120 employees.

Stock update

Shares of Graphite Bio Inc opened at $2.2 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.18 - $2.24, and closed at $2.22.

This is a +1.83% increase from the previous day's closing price.

A total volume of 45,891 shares were traded at the close of the day’s session.

In the last one week, shares of Graphite Bio Inc have slipped by -1.33%.

Graphite Bio Inc's Key Ratios

Graphite Bio Inc has a market cap of $130.46 million, indicating a price to book ratio of 0.6064 and a price to sales ratio of 0.

In the last 12-months Graphite Bio Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-94898000. The EBITDA ratio measures Graphite Bio Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Graphite Bio Inc’s operating margin was 0% while its return on assets stood at -19.06% with a return of equity of -45.69%.

In Q2, Graphite Bio Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Graphite Bio Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-2.15 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Graphite Bio Inc’s profitability.

Graphite Bio Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.874. Its price to sales ratio in the trailing 12-months stood at 0.

Graphite Bio Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$287.04 million

Total Liabilities

$12.27 million

Operating Cash Flow

$0

Capital Expenditure

$5.61 million

Dividend Payout Ratio

0%

Graphite Bio Inc ended 2024 with $287.04 million in total assets and $0 in total liabilities. Its intangible assets were valued at $287.04 million while shareholder equity stood at $224.15 million.

Graphite Bio Inc ended 2024 with $0 in deferred long-term liabilities, $12.27 million in other current liabilities, 1000.00 in common stock, $-321651000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $128.51 million and cash and short-term investments were $246.67 million. The company’s total short-term debt was $2,914,000 while long-term debt stood at $0.

Graphite Bio Inc’s total current assets stands at $251.17 million while long-term investments were $0.00 and short-term investments were $118.16 million. Its net receivables were $0 compared to accounts payable of $2.72 million and inventory worth $0.

In 2024, Graphite Bio Inc's operating cash flow was $0 while its capital expenditure stood at $5.61 million.

Comparatively, Graphite Bio Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.22

52-Week High

$3.91

52-Week Low

$1.59

Analyst Target Price

$3.6

Graphite Bio Inc stock is currently trading at $2.22 per share. It touched a 52-week high of $3.91 and a 52-week low of $3.91. Analysts tracking the stock have a 12-month average target price of $3.6.

Its 50-day moving average was $2.51 and 200-day moving average was $2.65 The short ratio stood at 10.15 indicating a short percent outstanding of 0%.

Around 920% of the company’s stock are held by insiders while 8018.2% are held by institutions.